Telithromycin: a new ketolide antimicrobial for treatment of respiratory tract infections. - Wikidata - awgldk - TriplyDB

Telithromycin: a new ketolide antimicrobial for treatment of respiratory tract infections.

Telithromycin: a new ketolide antimicrobial for treatment of respiratory tract infections.

http://www.wikidata.org/entity/Q31936145

about

Comparison of in vitro activities of ketolides, macrolides, and an azalide against the spirochete Borrelia burgdorferi Therapies in development for community-acquired pneumonia.Antibiotics in the treatment of acute exacerbations of chronic bronchitis.Clinical microdialysis in skin and soft tissues: an update.Dead bugs don't mutate: susceptibility issues in the emergence of bacterial resistance.Fluoroquinolone AUIC break points and the link to bacterial killing rates. Part 2: human trials.Optimizing antibacterial therapy for community-acquired respiratory tract infections in children in an era of bacterial resistance.3D-QSAR and molecular docking for the discovery of ketolide derivatives.Pharmacokinetics of telithromycin in plasma and soft tissues after single-dose administration to healthy volunteers.

P2860

Q31034198-BA99BD3B-0FD7-4CA8-8910-283A7E1B49CF Q34581508-A4214A79-38E7-4D47-9A68-D4132B9CF5CF Q34706968-66E3C93C-4C83-4CFE-9CB3-727049CFB48F Q34752069-43DBA19A-C093-45B7-90CB-9EF0E493865B Q35047705-C8D82E8B-E240-4A01-ADFD-918DF90F0EFB Q35547236-391D77EE-FB01-4955-AC40-3C15FCEA509D Q35692693-6466AAF3-8709-435A-9783-3C1438067F1E Q38084701-96098DB4-A35D-4DEE-9160-44003738971C Q40425618-EBB7CB2D-F17A-4E78-9251-372AE1170610

P2860

Telithromycin: a new ketolide antimicrobial for treatment of respiratory tract infections.

http://www.wikidata.org/entity/Q31936145

description

2001 nî lūn-bûn

@nan

2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Telithromycin: a new ketolide ...... respiratory tract infections.

@ast

Telithromycin: a new ketolide ...... respiratory tract infections.

@en

type

label

Telithromycin: a new ketolide ...... respiratory tract infections.

@ast

Telithromycin: a new ketolide ...... respiratory tract infections.

@en

prefLabel

Telithromycin: a new ketolide ...... respiratory tract infections.

@ast

Telithromycin: a new ketolide ...... respiratory tract infections.

@en

P1433

Q31936145-0627E028-7A7B-4E49-9975-6B83F2FA5989

P1476

Q31936145-BCF07641-C376-4E57-BADF-5F46C1018E46

P2093

Q31936145-3A7C7415-EBDF-4CBC-A16C-7F4CEB7637F5

Q31936145-DD9C07AF-9284-494D-AC69-0399224F3683

P2860

Q31936145-02AE325E-F83F-4DDE-9EAB-93415EF37B2B

Q31936145-0BC49D98-8100-4B47-9359-920F05EFBC82

Q31936145-18FF35C5-89E1-437A-856F-FB0F36212375

Q31936145-3FEC2E1F-64DF-43EB-B481-EE0EF33A8EF6

Q31936145-6EF43627-4749-4A4C-A23E-103842186A43

Q31936145-7381D98F-80D1-48C5-87E0-6EB40000CA0D

Q31936145-76537A84-6CDE-4792-A1C6-485E6A3C0BDC

Q31936145-7A2BA8A7-4D6B-4D54-AF20-DC46EE12EEE9

Q31936145-B25B9F29-1232-4EC6-B7DA-DAB23B8228E2

Q31936145-CF1808A1-F970-46F0-AA19-91FEDCE1542C

P304

Q31936145-3E4F4B5F-045F-4D21-84D6-423F263488AB

P31

Q31936145-07E4E465-C8B7-4ECB-A336-8B08DAE8251C

P356

Q31936145-22199C53-5A42-4654-80F3-9716A0A89CB6

P407

Q31936145-4676DCAA-7CC8-4FB1-9CD5-34E99978386F

P433

Q31936145-9AFCA563-F65C-406E-8B32-1C4ED7EBA4A8

P478

Q31936145-296730D3-3043-4622-919E-4CDA9016027D

P577

Q31936145-16D8B1ED-809A-4646-804B-DEC08405CDDE

P698

Q31936145-3D6E4821-9539-4F67-A080-7A811310C4A2

P356

13543784.10.2.353

P1433

Expert Opinion on Investigational Drugs

P1476

Telithromycin: a new ketolide ...... respiratory tract infections.

@en

P2093

H M Yassin

http://www.w3.org/2001/XMLSchema#string

L L Dever

http://www.w3.org/2001/XMLSchema#string

P2860

A prediction rule to identify low-risk patients with community-acquired pneumonia

In vitro activities of the ketolides telithromycin (HMR 3647) and HMR 3004 compared to those of clarithromycin against slowly growing mycobacteria at pHs 6.8 and 7.4

In vitro development of resistance to telithromycin (HMR 3647), four macrolides, clindamycin, and pristinamycin in Streptococcus pneumoniae

In vitro activities of telithromycin (HMR 3647) against Rickettsia rickettsii, Rickettsia conorii, Rickettsia africae, Rickettsia typhi, Rickettsia prowazekii, Coxiella burnetii, Bartonella henselae, Bartonella quintana, Bartonella bacilliformis, an

New research in macrolides and ketolides since 1997.

The in-vitro activity of HMR 3647, a new ketolide antimicrobial agent.

Comparative activities of telithromycin (HMR 3647), levofloxacin, and other antimicrobial agents against human mycoplasmas.

Use of ketolides in combination with other drugs to treat experimental toxoplasmosis.

In vitro activity of the novel ketolide HMR 3647 and comparative oral antibiotics against Canadian respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.

Inhibition of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells by 11 different ketolide antibiotics.

P304

353-367

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.10.2.353

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2001-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11178347

http://www.w3.org/2001/XMLSchema#string